JUL 05, 2020 12:33 PM PDT

Iron Build-up in Brain Linked to Alzheimer's

WRITTEN BY: Annie Lennon

Researchers from the Medical University of Graz in Austria have found a link between the build-up of iron in the brain's neocortex and cognitive decline in people with Alzheimer's disease.

Previous research has already established a link between unusually high levels of iron in the brain and Alzheimer's disease. In particular, iron deposits have been found to correlate with amyloid-beta accumulation, a protein that forms plaques between neurons in the brains of people with Alzheimer's and disrupts cell function. 

For the new study, the researchers developed a new MRI technique using a 3T MRI scanner, that allowed them to achieve an optimal trade-off between resolution and scan time, to best map iron deposits in different areas of the participants' brains. 

In particular, they used it to examine baseline levels of brain iron in 100 people with Alzheimer's disease and 100 healthy controls. Among those with Alzheimer's, 56 also underwent neuropsychological testing and brain MRI at an average follow-up time of 17 months. 

"We found indications of higher iron deposition in the deep gray matter and total neocortex, and regionally in temporal and occipital lobes, in Alzheimer's disease patients compared with age-matched healthy individuals," says Dr. Reinhold Schmidt, one of the study's co-authors. 

Iron accumulation also was linked to cognitive deterioration independently of loss in brain volume. Furthermore, iron concentration changes in the temporal lobes were found to correlate with cognitive decline in those with Alzheimer's. 

Schmidt thus concludes that these results are in line with previous suggestions that high iron concentrations encourage amyloid-beta deposits to form alongside general neurotoxicity associated with Alzheimer's. 

The researchers are hopeful that their findings will inform the use of drugs, known as chelators, to reduce iron levels in the brain and body. They also hope that their MRI-based screening method will be used as a future diagnostic tool for Alzheimer's and to monitor treatment response. 

 

Sources: Neuroscience NewsTechnology Networks 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
SEP 01, 2020
Clinical & Molecular DX
Scalp Implants Monitor Epileptic Seizures
SEP 01, 2020
Scalp Implants Monitor Epileptic Seizures
Neuroscientists have developed devices that, when implanted under the scalp of individuals living with epilepsy, can mon ...
SEP 11, 2020
Cannabis Sciences
Frequent Cannabis Use Does Not Increase Pain Sensitivity
SEP 11, 2020
Frequent Cannabis Use Does Not Increase Pain Sensitivity
Researchers from the University of British Columbia have found that frequent cannabis use is not associated with increas ...
SEP 21, 2020
Neuroscience
Insufficient Sleep Makes It Harder to Enjoy Life, Study Says
SEP 21, 2020
Insufficient Sleep Makes It Harder to Enjoy Life, Study Says
A growing body of research stresses the importance of getting a good night's sleep- whether it's to bolster your ...
SEP 21, 2020
Cannabis Sciences
Why Do We Build Tolerance to Cannabis?
SEP 21, 2020
Why Do We Build Tolerance to Cannabis?
Many notice that after regularly smoking cannabis, it takes more and more to feel its effects- if any at all. While abst ...
SEP 29, 2020
Cell & Molecular Biology
What We Call Parkinson's Disease May Actually be Two Distinct Disorders
SEP 29, 2020
What We Call Parkinson's Disease May Actually be Two Distinct Disorders
Researchers have used imaging tools to show that Parkinson's disease may actually be two different diseases, one that st ...
OCT 03, 2020
Clinical & Molecular DX
Test Diagnoses Dementia While You Sleep by Estimating Your Brain Age
OCT 03, 2020
Test Diagnoses Dementia While You Sleep by Estimating Your Brain Age
Researchers at Harvard have discovered a novel diagnostic marker of dementia for identifying undiagnosed patients or tho ...
Loading Comments...